• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Clementia - Articles and news items

Success for Clementia’s Phase II Fibrodysplasia Ossificans Progressiva trial

Industry news / 18 October 2016 / Niamh Louise Marriott, Digital Content Producer

Palovarotene was well-tolerated, with all subjects completing the 12-week trial and enrolling into the open-label extension trial…


Webinar: NIR Spectroscopy for Assessing Blend Uniformity in the Pharmaceutical IndustryLEARN MORE
+ +